Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Aepfelbacher M et al. Cholesterol modulates PAF-stimulated Ca2(+)-mobilization in monocytic U937 cells. 1991 Biochim. Biophys. Acta pmid:2043662
Kern H et al. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group. 1998 Biochim. Biophys. Acta pmid:9767093
Hopkins NK et al. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer. 1984 Biochim. Biophys. Acta pmid:6089913
Liapikos TA et al. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. 1994 Biochim. Biophys. Acta pmid:8199206
Roy Baker R and Chang Hy MgATP may depress de novo neuronal nuclear PAF generation by promoting the formation of alkylacylglycerophosphate, an inhibitor of alkylglycerophosphate acetyltransferase. 2002 Biochim. Biophys. Acta pmid:12457714
Baker RR and Chang HY Neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor are located in the nuclear envelope and show differential losses in activity. 1997 Biochim. Biophys. Acta pmid:9106499
Pestonjamasp VK and Burstein SH Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. 1998 Biochim. Biophys. Acta pmid:9795237
Kawaguchi H et al. Mechanism of increased angiotensin-converting enzyme activity stimulated by platelet-activating factor. 1990 Biochim. Biophys. Acta pmid:2162220
Ninio E et al. Biosynthesis of platelet-activating factor (PAF-acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187. 1983 Biochim. Biophys. Acta pmid:6405792
Kumar R et al. Metabolism of platelet-activating factor (alkylacetylphosphocholine) by type-II epithelial cells and fibroblasts from rat lungs. 1987 Biochim. Biophys. Acta pmid:3790610
Sugiura T et al. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes. 1990 Biochim. Biophys. Acta pmid:2123719
Goldman R et al. Calcium-dependent PAF-stimulated generation of reactive oxygen species in a human keratinocyte cell line. 1999 Biochim. Biophys. Acta pmid:10366777
Drapier JC et al. Lipid-mediator synthesis in peritoneal macrophages from mice injected with immunostimulants. 1983 Biochim. Biophys. Acta pmid:6131693
Schaloske RH et al. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages. 2005 Biochim. Biophys. Acta pmid:15708354
Maguire MH and Csonka-Khalifah L Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs. 1987 Biochim. Biophys. Acta pmid:3117116
Blache D and Ciavatti M Rat platelet arachidonate metabolism in the presence of Ca2+, Sr2+ and Ba2+: studies using intact platelets and semi-purified phospholipase A2. 1987 Biochim. Biophys. Acta pmid:2444263
Sturk A et al. Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids. 1989 Biochim. Biophys. Acta pmid:2512985
Hampel G et al. Selenium deficiency inhibits prostacyclin release and enhances production of platelet activating factor by human endothelial cells. 1989 Biochim. Biophys. Acta pmid:2512981
Comminges C et al. Studies on ether-phospholipids of vascular smooth muscle cells. Identification of a rapid Ca(2+)-dependent hydrolysis of alkyl-phosphatidylethanolamine promoted by endothelin-l. 1997 Biochim. Biophys. Acta pmid:9030203
Lauener RW et al. A role for phosphatidylinositol 3-kinase in platelet aggregation in response to low, but not high, concentrations of PAF or thrombin. 1999 Biochim. Biophys. Acta pmid:10559473
Leyravaud S and Benveniste J Regulation of cellular retention of paf-acether by extracellular pH and cell concentration. 1989 Biochim. Biophys. Acta pmid:2775773
Stanca E et al. Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: potential antiinflammatory effect of silybin. 2013 Biochim. Biophys. Acta pmid:23851051
Xie X et al. Interdigitation of bilayers from ether lipid analogs: (R)-PAF, (R)-Lyso-PAF and the antineoplastic (R)-ET-18-OMe. 1996 Biochim. Biophys. Acta pmid:8765102
Baker RR and Chang HY Alkylglycerophosphate acetyltransferase and lyso platelet activating factor acetyltransferase, two key enzymes in the synthesis of platelet activating factor, are found in neuronal nuclei isolated from cerebral cortex. 1996 Biochim. Biophys. Acta pmid:8765148
Bratton DL et al. Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. 1988 Biochim. Biophys. Acta pmid:3370214
Wang J et al. The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells. 1988 Biochim. Biophys. Acta pmid:3370222
Clark PO et al. Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. 1980 Biochim. Biophys. Acta pmid:7357030
Teng CM et al. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. 1985 Biochim. Biophys. Acta pmid:3926005
Samples BL et al. Subcellular localization of enzyme activities involved in the metabolism of platelet-activating factor in rainbow trout leukocytes. 1999 Biochim. Biophys. Acta pmid:10101269
Okayasu T et al. Metabolism of platelet-activating factor in primary cultured adult rat hepatocytes by a new pathway involving phospholipase C and alkyl monooxygenase. 1986 Biochim. Biophys. Acta pmid:3947669
Sawyer DB and Andersen OS Platelet-activating factor is a general membrane perturbant. 1989 Biochim. Biophys. Acta pmid:2480815
Sugiura T et al. Platelet-activating factor and its structural analogues in the earthworm Eisenia foetida. 1995 Biochim. Biophys. Acta pmid:7654776
Rao GH et al. Human platelet activation by an alkylacetyl analogue of phosphatidylcholine. 1982 Biochim. Biophys. Acta pmid:6280777
Murphy CT et al. Comparison of the role of protein kinase C in platelet functional responses induced by three different mechanisms, PAF, ionomycin and arachidonic acid. 1991 Biochim. Biophys. Acta pmid:1661165
Bratton DL et al. Effects of platelet activating factor on calcium-lipid interactions and lateral phase separations in phospholipid vesicles. 1988 Biochim. Biophys. Acta pmid:3401478
Tanaka T et al. Formation of platelet-activating factor-like phospholipids by Fe2+/ascorbate/EDTA-induced lipid peroxidation. 1993 Biochim. Biophys. Acta pmid:8443246
Giannattasio G et al. Expression of phospholipases A2 in primary human lung macrophages: role of cytosolic phospholipase A2-alpha in arachidonic acid release and platelet activating factor synthesis. 2009 Biochim. Biophys. Acta pmid:19130898
Snyder F Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. 1995 Biochim. Biophys. Acta pmid:7857964
Ninio E et al. Biosynthesis of paf-acether. XI. Regulation of acetyltransferase by enzyme-substrate imbalance. 1988 Biochim. Biophys. Acta pmid:3196734
Kumar R et al. Production and effects of platelet-activating factor in the rat brain. 1988 Biochim. Biophys. Acta pmid:3196741
Sugimoto S et al. Purification and characterization of lysophospholipase D from rat brain. 2006 Biochim. Biophys. Acta pmid:17071136
Blank ML et al. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells. 1986 Biochim. Biophys. Acta pmid:3707974
Bratton DL et al. A model for the extracellular release of PAF: the influence of plasma membrane phospholipid asymmetry. 1991 Biochim. Biophys. Acta pmid:1705442
Alonso MT et al. Effects of the antithrombitic agent PCA 4230 on agonist-induced Ca2+ entry and Ca2+ release in human platelets. 1992 Biochim. Biophys. Acta pmid:1312357
Nagpurkar A et al. Effect of rat phosphorylcholine-binding protein on platelet aggregation. 1988 Biochim. Biophys. Acta pmid:3167098
Williams KA and Haslam RJ Effects of NaCl and GTP on the inhibition of platelet adenylate cyclase by 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (synthetic platelet-activating factor). 1984 Biochim. Biophys. Acta pmid:6696908
Heller R et al. Protein kinase C and cyclic AMP modulate thrombin-induced platelet-activating factor synthesis in human endothelial cells. 1991 Biochim. Biophys. Acta pmid:1710933
Joly F et al. Heterogeneity of arachidonate and paf-acether precursor pools in mast cells. 1992 Biochim. Biophys. Acta pmid:1596519
Krump E and Borgeat P Kinetics of 5-lipoxygenase activation, arachidonic acid release, and leukotriene synthesis in human neutrophils: effects of granulocyte-macrophage colony-stimulating factor. 1994 Biochim. Biophys. Acta pmid:8025123
Robinson M and Snyder F Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species. 1985 Biochim. Biophys. Acta pmid:4052436
Chabot MC et al. Reacylation of platelet activating factor with eicosapentaenoic acid in fish-oil-enriched monkey neutrophils. 1987 Biochim. Biophys. Acta pmid:2823907
Salgado J et al. Effects of platelet-activating factor and related lipids on dielaidoylphosphatidylethanolamine by DSC, FTIR and NMR. 1993 Biochim. Biophys. Acta pmid:8431461
Tokumura A et al. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes. 1990 Biochim. Biophys. Acta pmid:2340312
Herrmann DB et al. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages. 1986 Biochim. Biophys. Acta pmid:3947667
Rosenthal MD et al. Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils. 1989 Biochim. Biophys. Acta pmid:2536283
Sneddon AA et al. Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid. 2006 Biochim. Biophys. Acta pmid:16829183
Kramer RM et al. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. 1988 Biochim. Biophys. Acta pmid:3355850
Turner MR and Lumb RH Synthesis of platelet activating factor by tissues from the rainbow trout, Salmo gairdneri. 1989 Biochim. Biophys. Acta pmid:2742873
Dupuis F et al. PAF and haematopoiesis. X. Macrophage colony-stimulating factor and granulocyte macrophage colony-stimulating factor enhance platelet-activating factor acetylhydrolase production by human blood-derived macrophages. 1996 Biochim. Biophys. Acta pmid:8603099
Meyer AF et al. Stereochemistry- and concentration-dependent effects of phosphatidylserine enrichment on platelet function. 2017 Biochim. Biophys. Acta pmid:28472616
Miller OV et al. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence. 1982 Biochim. Biophys. Acta pmid:6285985
Mori M et al. Energy-dependent export of leukotriene B4 in Xenopus oocytes. 1993 Biochim. Biophys. Acta pmid:8389202
Balestrieri ML et al. Endothelial progenitor cells express PAF receptor and respond to PAF via Ca(2+)-dependent signaling. 2010 Biochim. Biophys. Acta pmid:20637897
O'Flaherty JT et al. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family. 1994 Biochim. Biophys. Acta pmid:8280772
Cabré F et al. Differential hydrolysis of 1-alkyl-2-acyl and diacylglycerophosphocholines by human and non-human phospholipases A2. 1992 Biochim. Biophys. Acta pmid:1576169
Tsoukatos DC et al. Studies on the subcellular distribution of 1-O-alkyl-2-acetyl-sn-glycero phosphocholine (PAF) and on the enzymic activities involved in its biosynthesis within the ciliate Tetrahymena pyriformis. 1993 Biochim. Biophys. Acta pmid:8218344
Sumita C et al. Pioglitazone induces plasma platelet activating factor-acetylhydrolase and inhibits platelet activating factor-mediated cytoskeletal reorganization in macrophage. 2004 Biochim. Biophys. Acta pmid:15279882
Bauldry SA et al. Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils. 1991 Biochim. Biophys. Acta pmid:1854803
Roy Baker R and Chang H Substrate specificities of neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor: differences in the use of 1-alkyl and 1-acyl lysophospholipid acceptors. 1998 Biochim. Biophys. Acta pmid:9507140
Samiei M et al. Activation of myelin basic protein and S6 peptide kinases in phorbol ester- and PAF-treated sheep platelets. 1993 Biochim. Biophys. Acta pmid:8385998
Weber C et al. Docosahexaenoic acid inhibits PAF and LTD4 stimulated [Ca2+]i-increase in differentiated monocytic U937 cells. 1991 Biochim. Biophys. Acta pmid:1836359
Gay JC and Murray JJ Differential effects of propranolol on responses to receptor-dependent and receptor-independent stimuli in human neutrophils. 1991 Biochim. Biophys. Acta pmid:1659906
Egea L et al. Increased production of the ether-lipid platelet-activating factor in intestinal epithelial cells infected by Salmonella enteritidis. 2008 Biochim. Biophys. Acta pmid:18442488
Nieuwland R et al. Effect of epinephrine on the regulation of Na+/H+ exchange in human platelets. 1993 Biochim. Biophys. Acta pmid:8389195
Bussolino F et al. Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture. 1987 Biochim. Biophys. Acta pmid:3024738
van den Bosch H et al. Ether lipid synthesis and its deficiency in peroxisomal disorders. 1993 Biochimie pmid:8507680
Tencé V et al. Release, purification, and characterization of platelet-activating factor (PAF). 1980 Biochimie pmid:17941181
Watschinger K and Werner ER Orphan enzymes in ether lipid metabolism. 2013 Biochimie pmid:22771767
Olivier JL et al. Influence of PAF-acether on lecithin-oriented multibilayers monitored by ESR: interaction of PAF-acether with cholesterol. 1989 Biochimie pmid:2541796
Murakami M and Lambeau G Emerging roles of secreted phospholipase A(2) enzymes: an update. 2013 Biochimie pmid:23022039
Nankar SA et al. Differential interaction of peptides derived from C-terminal domain of human apolipoprotein E with platelet activating factor analogs. 2013 Biochimie pmid:23376877
Yost CC et al. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. 2010 Biochimie pmid:20167241
Tokumura A et al. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis. 2000 Biofactors pmid:11237195
Grambow E et al. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity. 2016 Biofactors pmid:27151562
Yoshikawa T et al. alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. 1998 Biofactors pmid:9523024
Zinchenko VP et al. [Effect of structural analogs of platelet activating factor on the intracellular signal transduction in murine peritoneal neutrophils and macrophages of P388D1 line]. 1997 Sep-Oct Biofizika pmid:9410037
Negresku EV et al. [Biochemical features of platelet alpha2-adrenergic receptors and their connection with an increase in concentration of intracellular Ca2+]. 1989 Biokhimiia pmid:2551395
Kuznetsova TI and Kulikov VI [The effect of aldehydogenic and acyl structural analogs of platelet activating factor on the formation of superoxide radicals by human blood leukocytes]. 1992 Biokhimiia pmid:1327185
Kulikov VI and Bergel'son LD [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes]. 1984 Biokhimiia pmid:6093897
Kulikov VI et al. [Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma]. 1984 Biokhimiia pmid:6542803
Muzia GI et al. [Interaction of 1-O-alkyl-2-methoxy-sn-glycero-3-phosphocholine and platelet activating factor with blood and tumor cells]. 1994 Biokhimiia pmid:7948414
Lichko LP et al. [The effect of PAF, sphingosine and heparin on certain phosphohydrolase and transport activity of yeast vacuoles]. 1994 Biokhimiia pmid:7948417
Kulikov VI and Muzia GI [Biological role of cellular metabolites--structural analogs of platelet activating factor]. 1996 Biokhimiia pmid:8724598
Muzia GI and Kulikov VI [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets]. 1996 Biokhimiia pmid:8724603
Kulikov VI and Muzia GI [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators]. 1992 Biokhimiia pmid:1420585
Muzia TI and Kulikov VN [1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine: acetylhydrolase is associated primarily with low density lipoproteins in human blood]. 1991 Biokhimiia pmid:1932343
Muzia GI et al. [Interaction of cells from murine organs with liposomes of various composition]. 1991 Biokhimiia pmid:1932348
Orlov SM et al. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs]. 1985 Biokhimiia pmid:2408682
Avdonin PV and Altukhova IP [Blocking with phorbol ester, a protein kinase C activator, of receptor-dependent platelet calcium channels]. 1985 Biokhimiia pmid:2416359
Avdonin PV et al. [Mechanism of increase in Ca2+ level in platelet cytoplasm induced by aggregating factors]. 1985 Biokhimiia pmid:3000463